GLP Watchdog

Navio MD vs TRT Nation

Neither Navio MD nor TRT Nation has an FDA warning letter on record. On compounded tirzepatide injection, Navio MD costs $360 less a year at standing rates: $189 a month against $219 a month at TRT Nation.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Navio MD / TRT Nation

Navio MD logo

Navio MD

8.5/10

TRT Nation logo

TRT Nation

6.0/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$189/moCompounded tirzepatide injection
$219/moCompounded tirzepatide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Navio MDFull review
Visit TRT NationFull review

Neither Navio MD nor TRT Nation pays us. Links to them earn nothing. Scores: Navio MD 8.5, TRT Nation 6.0. How we are paid

What the record shows

  1. 01

    Neither Navio MD nor TRT Nation has an FDA warning letter on record.

  2. 02

    Navio MD names The Pharmacy Hub, a 503A pharmacy. TRT Nation names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Navio MD costs $360 less a year at standing rates: $189 a month against $219 a month at TRT Nation.

  4. 04

    Only Navio MD lists a price for brand-name tirzepatide pen.

  5. 05

    Navio MD lists all 50 states. TRT Nation publishes no state list.

  6. 06

    Navio MD does not state its cancellation terms; TRT Nation holds you to a three-month minimum purchase on tirzepatide.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Navio MD

TRT Nation

Compounded tirzepatide injection

$189/moLower

$2,268 a year

$219/mo

$2,628 a year

Brand-name tirzepatide pen

$445/mo

$5,340 a year

Not sold or not priced
Cancel any time
Not stated
No
Minimum term
Not stated
Three-month minimum purchase on tirzepatide
Refunds
Not stated
The company keeps the right to refuse refunds and returns on every order

Read off each seller’s own pages. Navio MD: October 17, 2026. TRT Nation: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Navio MD

8.5/10
  • $360 a year less on compounded tirzepatide injection
  • Sells brand-name tirzepatide pen, which TRT Nation does not price
  • Names its compounding pharmacy
Visit Navio MD

The case for TRT Nation

6.0/10

The record gives TRT Nation no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Minimum commitment before you can cancel
Visit TRT Nation

Scores

Navio MD 8.5 · TRT Nation 6.0 out of 10. Six weighted parts.

Value25%

7.0A
vs
B
5.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

10.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Navio MD vs TRT Nation: questions

Neither Navio MD nor TRT Nation has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Navio MD names The Pharmacy Hub, a 503A pharmacy. TRT Nation names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Navio MD, by $360 a year at standing rates. Navio MD: $189 a month, about $2,268 a year. TRT Nation: $219 a month, about $2,628 a year.
Navio MD does not state its cancellation terms. TRT Nation has a minimum term (three-month minimum purchase on tirzepatide).
Neither Navio MD nor TRT Nation pays us. Links to them earn nothing. Scores: Navio MD 8.5, TRT Nation 6.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks